Tennessee Onc., PLLC - SCRI — Nashville, Tennessee

Tennessee Onc., PLLC - SCRI is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Onc., PLLC - SCRI has participated in 4 clinical trials.

Therapeutic areas: Triple-Negative Breast Cancer, Colorectal Cancer, Diffuse Large B-Cell Lymphoma.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Onc., PLLC - SCRI?

Tennessee Onc., PLLC - SCRI has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Onc., PLLC - SCRI conducted?

Tennessee Onc., PLLC - SCRI has 4 clinical trials on record. Their work covers Triple-Negative Breast Cancer, Colorectal Cancer, Diffuse Large B-Cell Lymphoma.

Is Tennessee Onc., PLLC - SCRI accredited by Crixeo Health?

Tennessee Onc., PLLC - SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Onc., PLLC - SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.